Literature DB >> 18040861

NAD+ and NADH in neuronal death.

Weihai Ying1.   

Abstract

Neuronal death is a key pathological event in multiple neurological diseases. Increasing evidence has suggested that NAD+ and NADH mediate not only energy metabolism and mitochondrial functions, but also calcium homeostasis, aging, and cell death. This article is written to provide an overview about the information suggesting significant roles of NAD+ and NADH in neuronal death in certain neurological diseases. Our latest studies have suggested that intranasal administration with NAD+ can profoundly decrease ischemic brain damage. These observations suggest that NAD+ administration may be a novel therapeutic strategy for some neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040861     DOI: 10.1007/s11481-007-9063-5

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  62 in total

1.  The parkinsonian toxin MPTP: action and mechanism.

Authors:  Serge Przedborski; Vernice Jackson-Lewis; Ruth Djaldetti; Gabriel Liberatore; Miquel Vila; Slobodanka Vukosavic; Gabrielle Almer
Journal:  Restor Neurol Neurosci       Date:  2000       Impact factor: 2.406

2.  A role of the Ca2+/Mg2+-dependent endonuclease in apoptosis and its inhibition by Poly(ADP-ribose) polymerase.

Authors:  A G Yakovlev; G Wang; B A Stoica; H A Boulares; A Y Spoonde; K Yoshihara; M E Smulson
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

3.  Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD+ depletion and cell death induced by oxidative stress.

Authors:  Lina Du; Xiaopeng Zhang; Yong Y Han; Nancy A Burke; Patrick M Kochanek; Simon C Watkins; Steven H Graham; Joseph A Carcillo; Csaba Szabó; Robert S B Clark
Journal:  J Biol Chem       Date:  2003-03-07       Impact factor: 5.157

4.  The role of NADPH oxidase and neuronal nitric oxide synthase in zinc-induced poly(ADP-ribose) polymerase activation and cell death in cortical culture.

Authors:  Yang-Hee Kim; Jae-Young Koh
Journal:  Exp Neurol       Date:  2002-10       Impact factor: 5.330

5.  Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study.

Authors:  V Demarin; Sarkanji S Podobnik; D Storga-Tomic; G Kay
Journal:  Drugs Exp Clin Res       Date:  2004

Review 6.  Oxidative stress signalling in Alzheimer's disease.

Authors:  Xiongwei Zhu; Arun K Raina; Hyoung-Gon Lee; Gemma Casadesus; Mark A Smith; George Perry
Journal:  Brain Res       Date:  2004-03-12       Impact factor: 3.252

7.  Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism.

Authors:  A S Mandir; S Przedborski; V Jackson-Lewis; Z Q Wang; C M Simbulan-Rosenthal; M E Smulson; B E Hoffman; D B Guastella; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 8.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

Review 9.  Physiological relevance of the endogenous mono(ADP-ribosyl)ation of cellular proteins.

Authors:  Maria Di Girolamo; Nadia Dani; Annalisa Stilla; Daniela Corda
Journal:  FEBS J       Date:  2005-09       Impact factor: 5.542

Review 10.  Functional aspects of protein mono-ADP-ribosylation.

Authors:  Daniela Corda; Maria Di Girolamo
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

View more
  9 in total

1.  Neuroimmune pharmacology expanding in Asia Pacific rim.

Authors:  Jialin C Zheng; Sheng-Di Chen
Journal:  J Neuroimmune Pharmacol       Date:  2007-07-24       Impact factor: 4.147

2.  Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation.

Authors:  Pascal Röderer; Lara Klatt; Felix John; Verena Theis; Konstanze F Winklhofer; Carsten Theiss; Veronika Matschke
Journal:  Mol Neurobiol       Date:  2018-03-16       Impact factor: 5.590

Review 3.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 4.  Promotion of cellular NAD(+) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer's disease.

Authors:  Nady Braidy; Gilles Guillemin; Ross Grant
Journal:  Neurotox Res       Date:  2008 May-Jun       Impact factor: 3.911

5.  Mutations in PYCR2, Encoding Pyrroline-5-Carboxylate Reductase 2, Cause Microcephaly and Hypomyelination.

Authors:  Tojo Nakayama; Almundher Al-Maawali; Malak El-Quessny; Anna Rajab; Samir Khalil; Joan M Stoler; Wen-Hann Tan; Ramzi Nasir; Klaus Schmitz-Abe; R Sean Hill; Jennifer N Partlow; Muna Al-Saffar; Sarah Servattalab; Christopher M LaCoursiere; Dimira E Tambunan; Michael E Coulter; Princess C Elhosary; Grzegorz Gorski; A James Barkovich; Kyriacos Markianos; Annapurna Poduri; Ganeshwaran H Mochida
Journal:  Am J Hum Genet       Date:  2015-04-09       Impact factor: 11.025

6.  PYCR2 Mutation Causing Hypomyelination and Microcephaly in an Indian Child.

Authors:  Preeti Srivastava; Asit Kumar Mishra; Nilanjan Sarkar
Journal:  Cureus       Date:  2021-04-24

7.  Nicotinamide Attenuates the Progression of Renal Failure in a Mouse Model of Adenine-Induced Chronic Kidney Disease.

Authors:  Satoshi Kumakura; Emiko Sato; Akiyo Sekimoto; Yamato Hashizume; Shu Yamakage; Mariko Miyazaki; Sadayoshi Ito; Hideo Harigae; Nobuyuki Takahashi
Journal:  Toxins (Basel)       Date:  2021-01-11       Impact factor: 4.546

Review 8.  The return of metabolism: biochemistry and physiology of the pentose phosphate pathway.

Authors:  Anna Stincone; Alessandro Prigione; Thorsten Cramer; Mirjam M C Wamelink; Kate Campbell; Eric Cheung; Viridiana Olin-Sandoval; Nana-Maria Grüning; Antje Krüger; Mohammad Tauqeer Alam; Markus A Keller; Michael Breitenbach; Kevin M Brindle; Joshua D Rabinowitz; Markus Ralser
Journal:  Biol Rev Camb Philos Soc       Date:  2014-09-22

9.  PYCR2 Mutations cause a lethal syndrome of microcephaly and failure to thrive.

Authors:  Maha S Zaki; Gifty Bhat; Tipu Sultan; Mahmoud Issa; Hea-Jin Jung; Esra Dikoglu; Laila Selim; Imam G Mahmoud; Mohamed S Abdel-Hamid; Ghada Abdel-Salam; Isaac Marin-Valencia; Joseph G Gleeson
Journal:  Ann Neurol       Date:  2016-06-01       Impact factor: 10.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.